Recently, PCDHGB7 methylation was identified as a diagnosis indicator for cervical cancer, endometrial cancer, and malignant body fluids which attracted more oncologists’ attention since its huge translational potential (14–16, 30). This evidence concerns the gene PCDHGB7 and cervical carcinoma.